FIBROSIS, LIVER
Clinical trials for FIBROSIS, LIVER explained in plain language.
Never miss a new study
Get alerted when new FIBROSIS, LIVER trials appear
Sign up with your email to follow new studies for FIBROSIS, LIVER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Diabetes pill may halt deadly liver scarring in hepatitis b
Disease control OngoingThis study is testing whether empagliflozin, a medication for diabetes, can prevent or slow the progression of liver scarring (fibrosis and cirrhosis) in people with chronic hepatitis B. The 106 participants are already taking standard antiviral drugs but still have significant l…
Matched conditions: FIBROSIS, LIVER
Phase: PHASE4 • Sponsor: The University of Hong Kong • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Can text messages and lifestyle changes reverse early liver damage?
Disease control OngoingThis study tests whether a 6-month personalized lifestyle program can help improve liver health in people with early signs of liver disease. Participants receive guidance on diet, exercise, alcohol use, and medication adherence through text messages and support. The goal is to se…
Matched conditions: FIBROSIS, LIVER
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Hidden liver risk in diabetes: quick scan seeks silent scarring
Knowledge-focused OngoingThis study aims to find out how common fatty liver disease and serious liver scarring are in adults with type 1 diabetes. Researchers will screen over 500 patients using a quick, non-invasive scan and blood tests. The goal is to identify patients at high risk who may need to see …
Matched conditions: FIBROSIS, LIVER
Sponsor: Joslin Diabetes Center • Aim: Knowledge-focused
Last updated Mar 19, 2026 14:55 UTC